C. A. Mdel

Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.

J. Esteve, J. Martinez-Climent, M. Tormo, 2001, Haematologica.